Position paper is available here.
The UK is a life sciences superpower. Its exceptional strength in the research and production of world-class medicines and vaccines has developed over many decades out of a strong science base, open approach to foreign investment in pharmaceuticals, a skilled manufacturing workforce, and robust culture of protecting innovation through intellectual property (IP) rights. Its regulators are recognised as among the most experienced and sophisticated in the world.